Principle and evolving role of intraperitoneal chemotherapy in ovarian cancer.

Item

http://www.wikidata.org/entity/Q38126548

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Principle and evolving role of intraperitoneal chemotherapy in ovarian cancer.

@en

type

Item

label

Principle and evolving role of intraperitoneal chemotherapy in ovarian cancer.

@en

prefLabel

Principle and evolving role of intraperitoneal chemotherapy in ovarian cancer.

@en

P1476

Principle and evolving role of intraperitoneal chemotherapy in ovarian cancer.

@en

P2093

Eriko Aotani

http://www.w3.org/2001/XMLSchema#string

Keiichi Fujiwara

http://www.w3.org/2001/XMLSchema#string

Kosei Hasegawa

http://www.w3.org/2001/XMLSchema#string

Shoji Nagao

http://www.w3.org/2001/XMLSchema#string

P2860

Phase II study of intraperitoneal carboplatin with intravenous paclitaxel in patients with suboptimal residual epithelial ovarian or primary peritoneal cancer: a Sankai Gynecology Cancer Study Group Study.

A phase I study with an expanded cohort to assess the feasibility of intraperitoneal carboplatin and intravenous paclitaxel in untreated ovarian, fallopian tube, and primary peritoneal carcinoma: A Gynecologic Oncology Group study.

A phase 3 trial of bevacizumab in ovarian cancer.

Principles and practice of intraperitoneal chemotherapy for ovarian cancer.

Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer.

Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer.

Incorporation of bevacizumab in the primary treatment of ovarian cancer.

Intraperitoneal carboplatin infusion may be a pharmacologically more reasonable route than intravenous administration as a systemic chemotherapy. A comparative pharmacokinetic analysis of platinum using a new mathematical model after intraperitoneal

First-line intraperitoneal carboplatin-based chemotherapy for 165 patients with epithelial ovarian carcinoma: results of long-term follow-up.

Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer.

P304

1797-1806

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14656566.2013.820705

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-08-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23915009

http://www.w3.org/2001/XMLSchema#string

P921

ovarian cancer